PL2529739T3 - Środek terapeutyczny lub profilaktyczny na choroby dróg żółciowych - Google Patents
Środek terapeutyczny lub profilaktyczny na choroby dróg żółciowychInfo
- Publication number
- PL2529739T3 PL2529739T3 PL11737151.8T PL11737151T PL2529739T3 PL 2529739 T3 PL2529739 T3 PL 2529739T3 PL 11737151 T PL11737151 T PL 11737151T PL 2529739 T3 PL2529739 T3 PL 2529739T3
- Authority
- PL
- Poland
- Prior art keywords
- therapeutic
- prophylactic agent
- biliary diseases
- biliary
- diseases
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010018730 | 2010-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2529739T3 true PL2529739T3 (pl) | 2016-12-30 |
Family
ID=44319422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11737151.8T PL2529739T3 (pl) | 2010-01-29 | 2011-01-28 | Środek terapeutyczny lub profilaktyczny na choroby dróg żółciowych |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10131672B2 (pl) |
| EP (1) | EP2529739B1 (pl) |
| JP (1) | JP5867081B2 (pl) |
| KR (1) | KR101732042B1 (pl) |
| CN (1) | CN102711759B (pl) |
| AU (1) | AU2011211223B2 (pl) |
| BR (1) | BR112012018765B1 (pl) |
| CA (1) | CA2787323C (pl) |
| ES (1) | ES2582628T3 (pl) |
| MX (1) | MX362830B (pl) |
| MY (1) | MY173491A (pl) |
| PH (1) | PH12012501552A1 (pl) |
| PL (1) | PL2529739T3 (pl) |
| RU (1) | RU2554857C2 (pl) |
| TW (1) | TWI477505B (pl) |
| WO (1) | WO2011093441A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013009505B1 (pt) * | 2010-10-19 | 2022-06-21 | Memorial Sloan-Kettering Cancer Center | Composto, composição farmacêutica, métodos para ensaio quanto a um receptor, e, usos de um composto |
| CN103327977B (zh) | 2011-01-31 | 2016-05-04 | 东丽株式会社 | 恶液质的治疗或预防剂 |
| EP4212532A3 (en) | 2015-04-30 | 2023-09-27 | Memorial Sloan Kettering Cancer Center | Mitragynine analogs and uses thereof |
| CN106110220B (zh) * | 2016-08-22 | 2020-01-07 | 陕西盘龙药业集团股份有限公司 | 一种治疗胆道疾病的中成药的制备工艺 |
| CA3091752A1 (en) | 2018-03-08 | 2019-09-12 | Victoria Link Ltd | Treatment of demyelinating diseases |
| CN118512451A (zh) | 2018-07-23 | 2024-08-20 | 特雷维治疗股份有限公司 | 慢性咳嗽、呼吸急促和呼吸困难的治疗 |
| WO2020205735A1 (en) * | 2019-03-29 | 2020-10-08 | Humanwell Pharmaceutical US | Novel morphinans useful for treating medical disorders |
| IL294601A (en) | 2020-01-10 | 2022-09-01 | Trevi Therapeutics Inc | Methods of administration of nalbuphine |
| MX2023014819A (es) | 2021-06-14 | 2024-03-21 | Scorpion Therapeutics Inc | Derivados de la urea que pueden ser utilizados para tratar el cancer. |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946848A (en) * | 1985-10-29 | 1990-08-07 | Baker Cumins Dermatologicals, Inc. | Method of treating pruritus with nalmefene and clonidine |
| WO1993000080A1 (en) * | 1991-06-24 | 1993-01-07 | Zeneca Ltd. | Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions |
| JP2525552B2 (ja) | 1992-01-23 | 1996-08-21 | 東レ株式会社 | モルヒナン誘導体および医薬用途 |
| CN1111900A (zh) | 1993-06-30 | 1995-11-15 | 东丽株式会社 | 止咳药 |
| KR100341950B1 (ko) | 1993-07-19 | 2002-11-29 | 도레이 가부시끼가이샤 | 뇌세포보호제 |
| DE69507697T2 (de) * | 1994-05-31 | 1999-06-10 | Mallinckrodt Chemical, Inc., Chesterfield, Mo. | Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält |
| CN1535687A (zh) | 1996-11-25 | 2004-10-13 | ������������ʽ���� | 止痒药物 |
| WO1999005146A1 (en) | 1997-07-25 | 1999-02-04 | Toray Industries, Inc. | Hyponatremia remedies |
| CA2270955C (en) | 1997-09-02 | 2007-08-07 | Toray Industries Inc. | Pharmaceutical composition containing morphinan derivative for treating drug dependence |
| JP2000053572A (ja) * | 1998-08-11 | 2000-02-22 | Toray Ind Inc | ＯＲＬ１（ｏｐｉｏｉｄ ｏｒｐｈａｎ）受容体拮抗薬 |
| ES2308990T3 (es) | 1999-08-24 | 2008-12-16 | Toray Industries, Inc. | Remedios para el dolor neuropatico y modelos animales de dolor neuropatico. |
| JP2001163784A (ja) | 1999-12-06 | 2001-06-19 | Toray Ind Inc | 角膜または結膜用止痒剤 |
| JP4453254B2 (ja) | 2001-03-30 | 2010-04-21 | 東レ株式会社 | レストレス・レッグズ症候群治療薬 |
| JP4239592B2 (ja) | 2001-05-08 | 2009-03-18 | 東レ株式会社 | 敗血症治療剤 |
| US20030054030A1 (en) * | 2001-09-13 | 2003-03-20 | Gary Gordon | Method and compositions for the treatment of pruritus |
| DE10161963A1 (de) * | 2001-12-17 | 2003-07-03 | Johannes Schuetz | 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung |
| US6852713B2 (en) | 2003-04-16 | 2005-02-08 | Adolor Corporation | Lactam derivatives and methods of their use |
| US6992193B2 (en) | 2003-06-10 | 2006-01-31 | Adolor Corporation | Sulfonylamino phenylacetamide derivatives and methods of their use |
| US7034051B2 (en) | 2003-08-28 | 2006-04-25 | Adolor Corporation | Fused bicyclic carboxamide derivatives and methods of their use |
| US7160902B2 (en) | 2003-11-14 | 2007-01-09 | Adolor Corporation | Amide derivatives and methods of their use |
| CN101137658B (zh) | 2005-03-10 | 2011-06-08 | 东丽株式会社 | 用于与多发性硬化症伴随的搔痒的止痒剂 |
| MX2009011449A (es) * | 2007-04-24 | 2010-01-25 | Toray Industries | Agente terapeutico o profilactico para disquinesia. |
| MX2009014181A (es) | 2007-06-22 | 2010-03-04 | Toray Industries | Remedio o preventivo para sindrome de disfuncion de integracion. |
| BRPI0817804A8 (pt) * | 2007-10-05 | 2017-04-18 | Toray Industries | Agente terapêutico para melhorar as propriedades da pele compreendendo um derivado de morfinano ou qualquer um de seus sais de adição de ácido farmacologicamente permissíveis como um ingrediente ativo |
| JP2011512360A (ja) * | 2008-02-14 | 2011-04-21 | アルカーメス，インコーポレイテッド | 選択的オピオイド化合物 |
| WO2009132313A2 (en) * | 2008-04-25 | 2009-10-29 | Progenics Pharmaceuticals, Inc. | Morphinan derivatives of organic and inorganic acids |
-
2011
- 2011-01-28 PH PH1/2012/501552A patent/PH12012501552A1/en unknown
- 2011-01-28 JP JP2011505302A patent/JP5867081B2/ja active Active
- 2011-01-28 BR BR112012018765A patent/BR112012018765B1/pt active IP Right Grant
- 2011-01-28 AU AU2011211223A patent/AU2011211223B2/en not_active Ceased
- 2011-01-28 PL PL11737151.8T patent/PL2529739T3/pl unknown
- 2011-01-28 TW TW100103337A patent/TWI477505B/zh active
- 2011-01-28 ES ES11737151.8T patent/ES2582628T3/es active Active
- 2011-01-28 MX MX2012008509A patent/MX362830B/es active IP Right Grant
- 2011-01-28 KR KR1020127022530A patent/KR101732042B1/ko active Active
- 2011-01-28 MY MYPI2012700506A patent/MY173491A/en unknown
- 2011-01-28 RU RU2012136826/04A patent/RU2554857C2/ru active
- 2011-01-28 EP EP11737151.8A patent/EP2529739B1/en active Active
- 2011-01-28 WO PCT/JP2011/051737 patent/WO2011093441A1/ja not_active Ceased
- 2011-01-28 US US13/522,784 patent/US10131672B2/en active Active
- 2011-01-28 CN CN201180007520.XA patent/CN102711759B/zh active Active
- 2011-01-28 CA CA2787323A patent/CA2787323C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102711759A (zh) | 2012-10-03 |
| CA2787323A1 (en) | 2011-08-04 |
| JPWO2011093441A1 (ja) | 2013-06-06 |
| KR20120139713A (ko) | 2012-12-27 |
| RU2554857C2 (ru) | 2015-06-27 |
| EP2529739A1 (en) | 2012-12-05 |
| BR112012018765B1 (pt) | 2019-09-03 |
| US20130203797A1 (en) | 2013-08-08 |
| BR112012018765A2 (pt) | 2016-05-03 |
| KR101732042B1 (ko) | 2017-05-02 |
| TWI477505B (zh) | 2015-03-21 |
| EP2529739A4 (en) | 2015-03-11 |
| MX362830B (es) | 2019-02-14 |
| MX2012008509A (es) | 2012-08-31 |
| CN102711759B (zh) | 2015-05-13 |
| PH12012501552A1 (en) | 2017-04-26 |
| CA2787323C (en) | 2017-08-29 |
| EP2529739B1 (en) | 2016-07-13 |
| WO2011093441A1 (ja) | 2011-08-04 |
| TW201200521A (en) | 2012-01-01 |
| AU2011211223A1 (en) | 2012-09-20 |
| ES2582628T3 (es) | 2016-09-14 |
| MY173491A (en) | 2020-01-29 |
| RU2012136826A (ru) | 2014-03-10 |
| AU2011211223B2 (en) | 2014-10-23 |
| JP5867081B2 (ja) | 2016-02-24 |
| US10131672B2 (en) | 2018-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS67768B1 (sr) | Terapijski agens koji indukuje citotoksičnost | |
| GB0908957D0 (en) | Therapeutic agents | |
| IL275350B (en) | Treatment of neoplastic diseases | |
| EP2586462A4 (en) | PROPHYLACTIC OR ALTERNATIVE AGENT FOR GENETIC DISEASES | |
| EP2529739A4 (en) | THERAPEUTIC OR PROPHYLACTIC AGGREGATE AGAINST GALLERY DISEASES | |
| IL224340A (en) | Sanitary cause | |
| EP2554541A4 (en) | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR FIBROMYALGIA | |
| IL245995A0 (en) | Prophylactic or medical agent for fibrosis | |
| ZA201301458B (en) | Therapeutic agent for pain | |
| GB0900484D0 (en) | Therapeutic agent | |
| PT2651251T (pt) | Composição para o tratamento de distúrbios metabólicos | |
| EP2601954A4 (en) | THERAPEUTIC FOR DISEASES | |
| PL2599487T3 (pl) | Środek terapeutyczny lub środek profilaktyczny przeciwko bólowi neuropatycznemu | |
| GB201003727D0 (en) | Therapeutic agent | |
| GB201010583D0 (en) | Therapeutic agents | |
| GB201012102D0 (en) | Therapeutic agents | |
| GB201012101D0 (en) | Therapeutic agents | |
| GB201010577D0 (en) | Therapeutic agents | |
| GB201010582D0 (en) | Therapeutic agents | |
| GB201012100D0 (en) | Therapeutic agents | |
| GB201014963D0 (en) | Therapeutic agents | |
| IL222623A (en) | Preparations and kits for medical treatment | |
| GB0902450D0 (en) | Therapeutic agents | |
| GB0903949D0 (en) | Therapeutic agents | |
| GB0907971D0 (en) | Therapeutic agents |